Enorama Pharma

About

Enorama Pharma AB is a Swedish pharmaceutical company specializing in medicated gums and nicotine delivery formats, based in Malmö, Sweden.

The company focuses on development, manufacturing, and sales of consumer-friendly oral nicotine products and medicated chewing gums containing generic pharmaceutical substances.

Enorama Pharma operates a subsidiary in Florida, USA.

Categories & manufacturing capabilities

• Nicotine replacement therapies: Medicinal nicotine chewing gums registered as pharmaceuticals; nicotine gum for commercialization and potential in-licensing.
• Tobacco-free nicotine pouches: 100% tobacco-free oral nicotine pouches sold under the NIC-S® brand; company develops, manufactures, and sells these directly.
• Medicated chewing gums: Consumer-friendly gums with generic substances via the ChewMed® platform; gums ready for commercialization.

Production & operational capabilities

• Full-spectrum operations: Product development, manufacturing, regulatory registration, commercialization, and sales.
• Manufacturing: In-house production of medicated gums and nicotine pouches using ChewMed® technology.
• Technology platform: ChewMed® optimized for medicated gum production.
• Licensing: Offers nicotine gum for in-licensing to partners.
• Market expansion: Active pursuit of authorizations beyond Sweden; global ambition.

Quality, compliance & regulatory positioning

• Regulatory status: Nicotine gum registered as a pharmaceutical product in Sweden (August 2019); ongoing market authorizations in multiple markets.
• Certifications: No additional certifications explicitly listed.

Customization & collaboration model

• Licensing & partnerships: Offers nicotine gum for in-licensing to partners.